INTRODUCTION
A ubiquitous DNA-binding protein RBP-J is evolutionarily conserved from nematode and fruit fly to human (1, 2) . Earlier studies in Drosophila revealed a pivotal role of Su(H), a Drosophila authlog of RBP-J, in neural development (3, 4) and showed that it genetically interacts with the Notch receptor that is involved in cell fate determination (5) . The mammalian Notch receptor also plays an important role in cell fate determination of many lineages including nerve, muscle, pancreas and lymphocytes (6) (7) (8) (9) . We have generated RBP-J knockout mice and demonstrated that the mice die before 10.5 days postcoitum with defects in somite and neural tube formations. The defects are quite similar to those observed in Notch1 knockout mice (10) , indicating a conservation of the Notch signaling across the distantly-related species. It has recently been shown that the intracellular region of the Notch receptor (hereafter designated as RAMIC) is proteolytically cleaved by interaction with the ligand and is translocated into the nucleus (11) (12) (13) . RBP-J directly interacts with RAMIC to activate transcription of downstream target genes such as mammalian homologs of Drosophila Hairy and Enhancer of split, HES-1 and HES-5 genes, which prevent cell differentiation (1) . Thus, RBP-J is a critical effector molecule that functions in the Notch signaling pathway.
RBP-J also interacts with Epstein-Barr virus nuclear antigen 2 (EBNA2), an essential protein for virus-induced immortalization of human B lymphocytes, to activate transcription (14, 15) . Whereas RBP-J functions as a transcriptional activator in the presence of RAMIC or EBNA2 (16) , it represses transcription in the absence of those interacting proteins (17, 18) . On the promoter of the adenoviral gene encoding the capsid protein polypeptide IX (pIX), RBP-J directly interacts with transcriptional co-activators of TFIID and TFIIA to perturb an optimal interaction between them, resulting in repression of the pIX promoter (19) . The other type of repression by RBP-J has been attributed to co-repressors binding to the repression domain of RBP-J (18, 20) . Several molecules such as SMRT, N-CoR, CIR and KyoT2 have been reported as candidates for co-repressors of RBP-J to date, and some of them recruit the histone deacetylase to RBP-J to repress transcription (21) (22) (23) .
RBP-J binds to two distinct domains of RAMIC, the RAM domain and the ankyrin (ANK) repeats. The RAM domain was originally isolated by yeast two-hybrid screening and was shown to strongly interact with the middle region (amino acids 196-372) of RBP-J (2, 16) . RAMIC competes with the corepressors for binding to this middle region of RBP-J through the RAM domain (21, 24) . On the other hand, the ANK repeats of RAMIC interact with RBP-J weakly but significantly (25, 26) . IC activates transcription less strongly than RAMIC (25) . Constitutively-active phenotypes by enforced expression of mouse Notch1 IC were abolished by missense mutations (M1 and M2) in the ANK repeats, which disrupted the weak interaction of the ANK repeats with RBP-J (25) (26) (27) . We also showed that the transactivation activity of RAMIC was abrogated by the M1 mutation even though it still interacted with RBP-J via the RAM domain (28) . This suggests that the interaction between RBP-J and the ANK repeats of RAMIC is *To whom correspondence should be addressed. Tel: +81 75 753 4371; Fax: +81 75 753 4388; Email: honjo@mfour.med.kyoto-u.ac.jp important for transactivation, but it has not been determined which region of RBP-J is involved in this interaction.
A mutational analysis of RBP-J is useful to understand the mode of interaction between RBP-J and RAMIC in transactivation. However, it is difficult to assess transcriptional activities of exogenously-expressed RBP-J because RBP-J is constitutively expressed in all the cells and tissues that have been examined so far (29, 30) . To investigate the interaction between RBP-J and RAMIC in transactivation, we adopted an OT11 fibroblastic cell line that carries the homozygous (-/-) mutation of RBP-J and the transgene of H-2K b -tsA58 (25) . Using this RBP-J-deficient cell line, we examined the transcriptional activity of RBP-J mutants. Their ability to bind to DNA, to the two RBP-J-binding domains (ANK and RAM) of Notch, and to several co-repressor molecules were also analyzed. Finally, we examined the transactivation activity of chimeric proteins between RBP-J and its homolog RBP-L, which can bind to the same recognition sequence as RBP-J, but cannot interact with either the RAM domain or the ANK repeats (31, 32) . These results indicate that the interactions between the N-and C-terminal regions of RBP-J and the ANK repeats of RAMIC are important for transactivation of RBP-J by RAMIC, which is consistent with previous reports (25, 28) .
MATERIALS AND METHODS

Construction of plasmids
Most of the RBP-J mutants used, including deletion mutants, were in the pCDM8 expression vectors as generated by Chung et al. (33) . Double mutants were combined from the mutants in pCDM8 and subcloned in pCMX (34) . Deletion mutants were generated from pCDM8 RBP-J by the polymerase chain reaction (PCR) and subcloned in pCMX. Ln (374-515 of RBP-L) were synthesized by PCR, combined to obtain the chimera constructs and subcloned in pCMX. For the GAL4-chimeras, the yeast GAL4 DNA binding region was derived from pGBT9 (Clontech), fused with the chimeras, and subcloned in pCMX. All RBP-J mutants, including the chimeras, were confirmed, by immunoblotting and immunofluorescent detection, as being expressed in the nuclei of OT11 cells. For GST-CID, the fragment of SMRT (amino acids 649-811) was generated by PCR and subcloned in pGEX4T-1 (Pharmacia). The other GST fusion proteins were prepared as reported previously (23, 31, 32) . For the VP16 activator constructs, VP16 was derived from pCMX-VP16 (28), fused with RAM or ANK repeat fragments synthesized from pEFBOSneo RAMIC myc by PCR, and subcloned in pEFBOSneo.
Cell culture and transient transfections
OT11 cells were maintained in Dulbecco's modified Eagle's medium containing 10% fetal bovine serum, 100 U/ml recombinant mouse interferon γ (Genzyme) and 100 U/ml penicillin (25) . Cells confluently plated in 3.5 cm dishes were maintained without interferon γ for 24 h and co-transfected with plasmid DNA using LipofectAMINE (Gibco BRL). Cells were harvested ∼40 h after transfection and luciferase activities in the cell extracts were measured in a Berthold luminometer, LumatLB9501 according to the manufacturer's instructions (Toyo Ink Corp.). Normalized luciferase activities (luciferase/ β-galactosidase ratio) from all the samples carried out in triplicate were compared. To evaluate the maximal transcriptional activities of RBP-J mutants, 1 µg of pEFBOSneo RAMIC myc, 0.5 µg of pGa981-6, 0.25 µg of pCMXlacZ, and increasing amounts (0-128 ng) of pCDM8 RBP-J were introduced in a well of OT11 cells. Different amounts of expression plasmids were supplemented with vector plasmids to make the total amount of DNA in each sample equivalent. Reporter plasmids of pGa981-6 and TK-MH100×4-LUC, and a plasmid for normalization of pCMX lacZ were described previously (28) .
In vitro binding assay with GST fusion proteins
Expression of glutathione S-transferase (GST) fusion proteins and in vitro interaction assays were performed as described previously (16, 31) . Relative radioactivities of in vitro-translated [ 35 S]methionine-labeled proteins were pre-estimated by SDS-PAGE and the same molar quantities of labeled proteins were then reacted with the GST fusion proteins. To evaluate relative affinities of deleted mutants for GST fusion proteins, the results were adjusted to take into account the number of methionines within each protein. The reactions were confirmed to be within a linear range. All kinds of in vitrotranslated [ 35 S]methionine-labeled proteins in this study were confirmed to have no interaction with GST proteins.
Electrophoretic mobility shift assay (EMSA)
EMSA was performed as described previously (16, 28) . In vitrotranslated [ 35 S]methionine-labeled proteins of wild-type RBP-J and mutants were quantitated by SDS-PAGE and the same molar quantity of each protein was reacted with the 32 P-labeled O54 probes containing the RBP-J binding sites (33) . The binding reaction was performed for 30 min at 20°C and then electrophoresed in a 4% polyacrylamide gel at 130 V for 2 h at 4°C. The gel was dried and analyzed using an Imaging Analyzer BAS1500 (Fuji Film).
Immunoblotting
Transfected OT11 cells were scraped into PBS(-), resuspended in 1× sample buffer (6.25 mM Tris-HCl pH 6.8, 3% SDS, 5% 2-mercaptoethanol, 0.05% bromophenol blue and 10% glycerol), boiled for 5 min, subjected to 10% SDS-PAGE and electrophoretically-transferred onto a nitrocellulose membrane. Western blotting was performed as described previously (28) with anti-RBP-J rat monoclonal antibody (T6719) (33) .
RESULTS
Characterization of RBP-J mutants in RBP-J-deficient OT11 cells
The endogenous expression of RBP-J has always hampered its mutational analysis in cultured cells. To overcome this problem, we used the fibroblastic cell line, OT11 carrying the homozygous (-/-) mutation of RBP-J and the transgene of H-2K b -tsA58 (25) . First, various RBP-J mutants described in our previous study (33) were transfected into OT11 cells, together with the expression construct of mouse Notch1 RAMIC ( Fig. 1 ) and the pGa981-6 luciferase reporter plasmid that harbors the hexamized RBP-J binding sites (25) . Increasing amounts of exogenous RBP-J augmented the transcriptional activity, reached a peak and then, in excess, reduced the activity. This is probably due to the competition of binding to RAMIC between DNA-bound and free RBP-J (7 and data not shown). To compare the transcriptional activity of mutant RBP-J constructs with that of wild-type RBP-J, their maximal activities, achieved with constant amounts of RAMIC and pGa981-6, were evaluated. Thirty-six RBP-J mutants exhibited peak activities ranging from 2 to 170% of that of wild-type RBP-J ( Fig. 2A) . We arbitrarily categorized the mutants into three groups according to their level of activity relative to wild-type: (i) high, activity >160% (one mutant); (ii) normal, activity 60-160% (22 mutants); (iii) low, activity <60% (13 mutants).
To understand the molecular basis for the fluctuation in transcriptional activities of the mutants, we evaluated their binding to DNA and transcriptional cofactors. The DNA-binding activity of the mutant RBP-J in COS7 cells had previously been analyzed by EMSA (16) and an essentially similar result was obtained by using in vitro translation products (Fig. 2B) . We also wanted to determine whether the binding activities to interacting molecules of RBP-J were affected by the mutations using in vitro-translated RBP-J mutants and the GST fusion proteins GST-RAM (the RAM domain of mouse Notch1), GST-CID (the CBF1/RBP-J interaction domain of SMRT), GST-KyoT2 (the RBP-J binding domain of KyoT2), and GST-ANK (the ANK repeats of mouse Notch1) (Figs 1 and 2C and D). This was because altered affinity for the activator (RAMIC) and/or co-repressors (SMRT or KyoT2) could be the cause of the differing transcriptional activity of RBP-J mutants.
EE259RS (mutant 14b), with an increased transcriptional activity (170%) displayed normal binding activity with DNA (16), GST-RAM and GST-KyoT2 but decreased binding activity with GST-CID (Fig. 2C ). This suggests that SMRT could be implicated in repression of RBP-J in OT11 cells and the increased transcriptional activity of EE259RS may result from its decreased binding to SMRT. However, EEF259AAA (mutant 15), at the same site as EE259RS, displayed normal transcriptional activity, despite its decreased binding activity with GST-CID (Fig. 2C) . This is probably because of the combined effects of its reduced binding to GST-RAM.
Two types of RBP-J mutants with reduced transactivation activity
We classified RBP-J mutants with decreased transcriptional activity into two subgroups: (i) mutants with decreased DNAbinding activity (type 1), or (ii) with normal DNA-binding activity (type 2). While all the type 1 mutations are found in the middle region of RBP-J (Jm, amino acids 202-370), all the type 2 mutations are located either in the N-terminal region (Jn, amino acids 1-201), or in the C-terminal region (Jc, amino acids 371-526) (Fig. 2E ). Transcriptional activities of the type 2 mutants in the N-terminal region (5a, KR185GS; 6, S194A; and 7a, KK196GS) are lower than that of wild-type, but higher than those of type 1 mutants ( Fig. 2A) . To confirm their decreased transcriptional activity, we generated three constructs bearing double mutations. All double mutants (5a+6, KR185GS+S194A; 5a+7a, KR185GS+KK196GS; 6+7a, S194A+KK196GS) displayed a lower transcriptional activity (<40%), comparable with that of the other type 1 mutants, suggesting that the N-terminal region of RBP-J is important for transactivation by Notch1 RAMIC.
In most cases, decreased DNA-binding activity of the type 1 mutants correlates well with decreased binding activities to GST-RAM, GST-CID and GST-KyoT2, except that R218H (mutant 9) and RY227GS (mutant 11a) showed normal binding activity to the RAM domain ( Fig. 2C and D) . It is reasonable that the transcriptional activities of the type 1 mutants are low because of their decreased DNA-binding activity. In contrast, the type 2 mutants showed normal binding activities to DNA and the interacting molecules ( Fig. 2 and Table 1 ), which leaves their reduced transcriptional activities unexplained.
N-and C-terminal regions of RBP-J interact with the ANK repeats of RAMIC
When the binding activities of RBP-J deletion constructs to GST-ANK, GST-CID and GST-KyoT2 were examined with the pull-down assay (Fig. 3A) , the strong binding region to the ANK repeats was mapped to amino acids 141-227 of RBP-J, which we designated the SAB (strong ANK-binding) domain, where most of the type 2 mutations were located (Fig. 3B ). This SAB domain shows no sequence similarity to known proteins in the database and its function, other than the ANKbinding, has not yet been elucidated. Compared with the fulllength form of RBP-J, mutants containing the SAB domain but not the middle region (∆Sph-Pvu, Dra-Kpn and Stop-Kpn) have much higher (>15-fold) affinities for the ANK repeats. These results suggest that the middle region of RBP-J may be inhibitory to the interaction of its N-terminal region with the ANK repeats. Deletion mutant DelRsa971, mainly composed of the C-terminal region, showed a comparable affinity to that of full-length RBP-J, and the RAM binding domain (amino acids 196-372), consisting of the middle region, showed a marginal affinity for the ANK repeats. These results demonstrate that the N-and C-terminal regions of RBP-J independently bind to the ANK repeats with different affinities. In agreement with replacement mutation analyses (Fig. 2D ), KyoT2 and CID interacted with the Jm region.
To evaluate the in vivo interaction of the type 2 mutants with the ANK repeats of RAMIC, we measured their transcriptional activity induced by either IC or ANK-VP16 (containing ANK repeats and the transactivation domain of VP16) ( Table 1 ). All the type 2 mutants, including doubles, displayed <60% wildtype transcriptional activity in association with IC and similarly-reduced levels in association with ANK-VP16. These in vivo results indicate that the decreased transcriptional activity of the type 2 mutants is due to reduced interaction with the ANK domain. The obvious contradiction with the GST pull-down assay (Fig. 2D) could be explained by the possibility that the in vivo interaction activity of RBP-J with IC or the ANK repeats may depend on interaction with other unidentified proteins and therefore differ from that in vitro.
Interaction between RBP-J and the ANK repeats is sufficient for transactivation
To address the functional significance of the interaction between RBP-J and the ANK repeats, several chimeric constructs of RBP-J and RBP-L were generated and their RAMIC-induced transcriptional activities were examined (Fig. 4) . RBP-L is a lung-specific homolog of RBP-J, which binds to the same DNA recognition sequence as RBP-J, but cannot interact with either the RAM domain or the ANK repeats (31, 32) . To avoid the influence of the DNA-binding ability of each construct on transcriptional activity we also examined the GAL4 fusion construct of each chimera between RBP-J and RBP-L. As shown in Figure 4B , RBP-L shows no transcriptional activity, as reported previously (31) . In contrast, the LJL construct, replacing the middle region of RBP-L with the same region of RBP-J, showed a transcriptional activity comparable with that of RBP-J, consistent with the previous report that the interaction between RBP-J and the RAM domain is sufficient for transactivation (24) . Intriguingly, the JLJ construct, replacing both the N-and C-terminal regions of RBP-L with the same regions of RBP-J, showed an even stronger transcriptional activity, suggesting that the interaction between RBP-J and the ANK repeats would be sufficient and important for transactivation as well. The JLL construct, containing only the N-terminal region of RBP-J, did not bind to DNA and the LLJ construct, containing only the C-terminal region of RBP-J, failed to activate transcription despite its DNA-binding activity which was comparable to that of JLJ. Thus, the N-terminal region of RBP-J appears to play a crucial role in transactivation and the failure to activate transcription by the LLJ construct may be due to the absence of the SAB region that strongly binds to the ANK repeats (Fig. 3B) .
To reinforce the contribution of interaction between RBP-J and the ANK repeats in transactivation, we also examined the transactivation activity of the chimeric proteins co-transfected with IC, RAM-VP16 (a fusion protein of the RAM domain with VP16), or ANK-VP16 (Fig. 1) . RBP-J, but not RBP-L, shown. An aliquot of 1 µg of pCDM8 RBP-J and mutants was transfected in a 3.5 cm dish of OT11 cells and one-tenth of lysate was applied, blotted and detected by anti-RBP-J antibody (T6719). Detected results were adjusted by background amounts and shown as relative amounts to wild-type RBP-J (with wild-type set at 100). Although anti-RBP-J antibody displays lower affinities for mutants 10 and 18a (33 and unpublished data), significant levels of all the type 2 mutants are expressed. All experiments were confirmed in triplicate. Table 1 . The interaction of type 2 RBP-J mutants with the ANK repeats of IC Relative transcriptional activities induced by Notch IC and ANK-VP16 (and RAMIC) of RBP-J mutants compared to wild-type RBP-J were evaluated by the same approach as described in Figure 1A (1 µg of pEFBOSneo IC or 0.25 µg of pEFBOSneo ANK-VP16 was reacted as an activator). Relative affinities of RBP-J mutants for GST fusion proteins were also evaluated in the GST pull-down assays as described in Figure 2D . To detect relative DNA-binding properties, the same amounts of in vitro-translated type 2 RBP-J mutants were reacted with the 32 P-labeled O54 probes and evaluated by EMSA in a linear range (16) . All activities are relative to wild-type RBP-J.
DNA
GST pull-down assays Transcriptional activity
wild-type RBP-J  100  100  100  100  100  100  100  100   5a  KR185GS  104  109  114  92  108  71  56  83   6  S194A  92  92  103  90  102  41  39  47   7a  KK196GS  102  135  101  90  99  49  53  67   5a+6  KR185GS+S194A  92  146  110  95  107  18  27  35   5a+7a  KR185GS+KK196GS  106  116  108  81  98  19  38  73   6+7a  S194A+KK196GS  104  95  107  80  97  23  34  55 2 6 I n s R s a 1 2 6 5 9 6 1 3 1 9 5 7 0 8 8 1 1 0 0 could transactivate the promoter by all the activators (Fig. 4C) . LJL was activated by RAMIC and RAM-VP16, but not by IC or ANK-VP16, indicating that it does not interact with the ANK repeats but that its interaction with the RAM domain is essential for transactivation. Conversely, JLJ was activated by constructs containing the ANK repeats (RAMIC, IC and ANK-VP16), but not by RAM-VP16. Furthermore, the degrees of transactivation activity induced by RAMIC and IC are similar, although they are different in the case of RBP-J. These results strongly suggest that the interaction between the N-and C-terminal regions of RBP-J and the ANK repeats of RAMIC play an important role in transactivation.
DISCUSSION
It was reported that the Notch ANK repeats would play an important role in transactivation of RBP-J by RAMIC although their interaction with RBP-J is relatively weak (25, 28) . In this study, we showed that RBP-J interacts with the ANK repeats of Notch1 RAMIC via its N-and C-terminal regions. In addition, we identified the novel SAB domain in the N-terminal region of RBP-J. Mutational analyses of exogenouslyexpressed RBP-J mutants indicated that the N-and C-terminal regions of RBP-J were important for transactivation by RAMIC in RBP-J-deficient OT11 cells. Finally, we showed that the ANK-binding region of RBP-J conferred transactivation potential on RBP-L, which is intrinsically inactive, in transactivation by Notch1 RAMIC. Taken together, these results indicate that the interaction between RBP-J and the Notch ANK repeats is important for transactivation.
A role for the physical interaction between RBP-J and the ANK-repeats of RAMIC in transactivation was previously analyzed by employing the M1 mutation that disrupts the interaction with RBP-J (25) . RAMIC with the M1 mutation fails to activate transcription although it does interact with RBP-J through the RAM domain (28) . This suggests that the weak interaction between RBP-J and the ANK repeats of RAMIC would be important for transactivation and that the ANK repeats might be involved in displacing co-repressors from RBP-J (28). The fact that type 2 mutations of RBP-J show similarly-reduced transcriptional activity induced by IC or ANK-VP16 as well as by RAMIC ( Fig. 1 and Table 1 ) seems to support the importance of the interaction between RBP-J and the ANK repeats in transactivation. The interaction of the type 2 mutants with the ANK repeats in RAMIC appears to be impaired in vivo although their in vitro binding activity to the ANK repeat alone is not altered. Obviously, we cannot exclude the possibility that their direct or indirect interaction with the unidentified co-activator molecule(s) might be affected. Recently, we reported the functional interactions between mouse Notch1 RAMIC and co-activator proteins with histone acetyltransferase activity, PCAF and GCN5 (35) . The ANK repeats and the C-terminal transactivation domain of RAMIC are both required for interactions with PCAF and GCN5, and these interactions were also decreased by the M1 mutation of the ANK repeats. It is possible that the type 2 mutations affect the formation of a ternary complex of RBP-J, RAMIC and PCAF or GCN5. Further investigations are required to clarify this possibility.
Full-length RBP-J interacts with the ANK repeats much less strongly than its N-terminal region containing the SAB domain (Fig. 3) . The fact that some mutations (8a, 18a, 21 and 22) in the middle region (amino acids 196-372) of RBP-J increased the binding activity to the ANK repeats (Fig. 2D) suggests that this region may have an inhibitory function on the interaction between the N-terminal region of RBP-J and the Notch ANK repeats. Two mutants in the Jm region, 8a (KV212GS) and 21 (FY314GS) retained normal transcriptional activity despite their decreased binding activities to DNA and GST-RAM. It is conceivable that their apparently normal transcriptional activities result from increased binding activity to the ANK repeats (Fig. 2) . In fact, the JLJ construct, without the RAM-binding region (Jm), displayed transactivation activity with IC at the same level as with RAMIC (Fig. 3B) , indicating that the absence of Jm augments interaction of the N-and C-terminal regions of RBP-J with the ANK repeats in IC. Although the molecular mechanism by which the interaction between the N-terminal region and the ANK repeats is weakened is currently unknown, the inhibitory regulation could be important for RAMIC-induced transactivation. Since the JLL construct, containing only the N-terminal region of RBP-J, lost DNA-binding activity, we constructed a fusion protein between JLL and the yeast GAL4 DNA binding domain (GAL4-JLL) and examined the transcriptional activity induced by RAMIC. However, it showed no transcriptional activity of the GAL4-dependent luciferase construct (Fig. 4B) , suggesting that the N-terminal region alone is not sufficient for transactivation activity. The C-terminal region of RBP-J also interacts with the ANK repeats, but its affinity for the ANK repeats is lower than that of the SAB domain and comparable to that of full-length RBP-J. The C-terminal region alone did not confer RAMIC-induced transactivation potential on RBP-L, despite the fact that the chimeric protein (LLJ) could bind to DNA. These results indicate that both the N-and C-terminal regions of RBP-J are required for transactivation by RAMIC and suggest that the two regions may interact with the ANK repeats in a cooperative manner in vivo. 
